BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8082624)

  • 1. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
    Leiderman DB
    Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
    Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
    Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.
    Neurology; 1993 Nov; 43(11):2292-8. PubMed ID: 8232945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
    Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin in generalized seizures.
    Chadwick D; Leiderman DB; Sauermann W; Alexander J; Garofalo E
    Epilepsy Res; 1996 Nov; 25(3):191-7. PubMed ID: 8956916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin in partial epilepsy. UK Gabapentin Study Group.
    Lancet; 1990 May; 335(8698):1114-7. PubMed ID: 1971862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin add-on for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (3):CD001415. PubMed ID: 10908495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.